Latest Breaking News On - Biosciences company profile - Page 12 : comparemela.com

IDEAYA Biosciences, Inc (NASDAQ:IDYA) Receives Average Rating of Buy from Brokerages

IDEAYA Biosciences, Inc (NASDAQ:IDYA) Receives Average Rating of Buy from Brokerages
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Zurcher kantonalbank zurich cantonalbankStifel nicolausOpaleye management incBiosciences company profileSecurities exchange commissionIdeaya biosciences incBiosciences incBerenberg bankMetlife investment managementLife insurance coGet free reportMarketbeat ratingsStock downJason throneExchange commissionKantonalbank zurich cantonalbank

IDEAYA Biosciences, Inc (NASDAQ:IDYA) Insider Sells $218,155 00 in Stock

IDEAYA Biosciences, Inc (NASDAQ:IDYA) Insider Sells $218,155 00 in Stock
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

Goldman sachs groupGeode capital managementBerenberg bankBiosciences company profileAmeriprise financial incSecurities exchange commissionBiosciences incIdeaya biosciences incJpmorgan chase coGet free reportJason throneExchange commissionStock downStreet groupCapital management

IDEAYA Biosciences, Inc (NASDAQ:IDYA) Receives Consensus Recommendation of Buy from Analysts

IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Get Free Report) has been assigned an average rating of “Buy” from the nine analysts that are covering the stock, MarketBeat.com reports. Nine research analysts have rated the stock with a buy rating. The average 12 month price objective among brokerages that have issued ratings on the stock in the […]

United statesBiosciences company profileJpmorgan chase coGoldman sachs groupCharles schwab investment management incBiosciences incIdeaya biosciences incLife insurance coGet free reportJason throneRetirement systemLife insuranceCharles schwab investment managementSchwab investment managementGet freeIdeaya biosciences

IGM Biosciences, Inc (NASDAQ:IGMS) Director Acquires $31,850 00 in Stock

IGM Biosciences, Inc. (NASDAQ:IGMS – Free Report) Director Jakob Haldor Topsoe bought 3,500 shares of IGM Biosciences stock in a transaction on Thursday, June 29th. The stock was acquired at an average cost of $9.10 per share, with a total value of $31,850.00. Following the acquisition, the director now owns 78,144 shares of the company’s […]

Nova scotiaJakob haldor topsoeBiosciences company profileIgm biosciences incVanguard group incBiosciences incMillennium managementBlackrock incPricet rowe associates incSecurities exchange commissionRoyal bankJpmorgan chase coFree reportDirector jakob haldor topsoeExchange commission

IGM Biosciences, Inc (NASDAQ:IGMS) Director Acquires $900,000 00 in Stock

IGM Biosciences, Inc. (NASDAQ:IGMS – Free Report) Director M Kathleen Behrens bought 112,500 shares of the stock in a transaction on Monday, June 26th. The shares were acquired at an average cost of $8.00 per share, for a total transaction of $900,000.00. Following the purchase, the director now owns 330,700 shares in the company, valued […]

M kathleen behrensEnsign peak advisors incUs bancorpIgm biosciences incJpmorgan chase coMorgan stanleyRoyal bankCubist systematic strategiesBiosciences incBiosciences company profileFree reportDirectorm kathleen behrensSystematic strategiesPeak advisors incFinancial advisorsDigm biosciences